Small Pharma Inc.
DMTTFOTCHealthcare
$0.11
$-0.01(-9.69%)
Market Cap$37505507
P/E Ratio—
52W High$0.1905
52W Low$0.045
Small Pharma Inc. (DMTTF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DMTTF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-02 | 2022-02 | 2021-02 |
|---|---|---|---|
| Revenue | |||
| Revenue | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | 100.00% |
| Operating Expenses | |||
| R&D Expenses | $0.01B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.01B | $0.00B |
| Total Operating Expenses | $0.02B | $0.02B | $0.01B |
| Operating Income | ($0.02B) | ($0.02B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.02B) | ($0.01B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | $0.00B |
| Net Income | ($0.02B) | ($0.02B) | ($0.01B) |
| Net Margin %(computed) | — | — | — |
| Per Share & EBITDA | |||
| EPS (Basic) | $-0.07 | $-0.07 | $-0.02 |
| Wtd Avg Shares | 0.32B | 0.31B | 0.31B |
| EBITDA | ($0.02B) | ($0.02B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · B
Explore more Small Pharma Inc. data
About Small Pharma Inc. (DMTTF) Income Statement
Small Pharma Inc. (DMTTF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, DMTTF reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.02B) — a net profit margin of —.
Frequently asked questions
DMTTF · 4 questionsSmall Pharma Inc. (DMTTF) reported revenue of $0.00B for 2023, down —% year-over-year.
DMTTF revenueDMTTF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08